Work package objectives:
The overall objective of WP10 is the design and implementation of an EU-wide, dynamic, harmonised, and sustainable Volunteer Registry for phase 2 & 3 vaccines clinical trials with an initial focus on the COVID-19 pandemic, and for the future expansion to any forthcoming European epidemic/pandemic. It will be built on the recently established German Volunteer Registry and is currently expanding to four other countries, with 12 other countries on the way. WP10 strives to expand volunteer registries from healthy individuals to patients in specific sub-groups which is an essential resource for the identification of eligible volunteers for phase 2 & 3 vaccine clinical trials and can also be used to facilitate access to populations underrepresented in current vaccine trials. The added values of VACCELERATE for vaccine developers lie in the specific expertise needed for vaccine trials, combined with access to volunteers with or without co-morbidities, in- and out-patient settings, and the capacity to enrol a high number of participants in a short period of time.
Zoi Dorothea Pana, MD, MSc, PhD
Lecturer in Pediatrics, Subspecialty Epidemiology, Infection Control and Prevention (EUC, CY), European University of Cyprus (EUC); Ministry of Health (CY), Cyprus